By Dr. Karen Ring for CIRM/Big3Bio: CIRM kicked off the 2016 International Society for Stem Cell Research (ISSCR) Conference in San Francisco with a public stem cell event yesterday that brought scientists, patients, patient advocates and members of the general public together to discuss the many ways stem cells are being used in the clinic [...]
From NPR: "This summer, diners in New York, San Francisco and Los Angeles will get their hands on a hamburger that has been five years in the making. The burger looks, tastes and smells like beef — except it's made entirely from plants. It sizzles on the grill and even browns and oozes fat when [...]
UPDATE: A federal ethics and biosafety panel has approved the trial - coverage: Nature: First CRISPR clinical trial gets green light from US panel STAT: Federal panel approves first use of CRISPR in humans PREVIOUS: Internet billionaire Sean Parker is funding the first proposed test of CRISPR gene-editing technology in human beings. It would mark the first clinical trial involving CRISPR. Excerpts [...]
Excerpt of coverage from GEN: "Under the BARDA contract, Cerus will receive initial funding of up to $30,750,939 to support activities related to a clinical trial to assess the safety and efficacy of Intercept RBCs compared to conventional RBCs in Puerto Rico, which has been impacted by the Zika virus epidemic. This funding also will [...]
From The Bio Report/Daniel Levine: "Despite a rapid advance of technology there’s been little change in the preclinical drug development process. Vium is hoping to change that by using sensors, automation, and bioinformatics to change the way data is gathered in the preclinical process to fuel better and faster decisions about the potential value of [...]
From Bloomberg: "Bill Maris, CEO Google Ventures, comments on artificial intelligence's impact on biotech, the prospects for Theranos and the venture capital environment. He speaks with Bloomberg's Emily Chang on "Bloomberg West" from the Bloomberg Technology Conference in San Francisco."
From Merck press release: "Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Afferent Pharmaceuticals announced today that the two companies have signed a definitive agreement under which Merck will acquire this privately held pharmaceutical company. Afferent Pharmaceuticals is a leader in the development of therapeutic candidates targeting the P2X3 receptor for [...]
From the new report from California Life Sciences Institute on the economic strength/aspects of Bay Area life science startups: "OVERVIEW Pre-Series A life science companies in the Bay Area are significantly impacting the local and state economy. This is the key finding of a survey of 137 Bay Area life science startups conducted by the California [...]
From Bloomberg Video: "Jessica Mega, Verily Life Sciences chief medical officer, discusses the company's breakthrough biotech goals and life sciences funding with Bloomberg's Emily Chang on 'Bloomberg West.'"
From KQED/Forum with Michael Krasny: "In just 20 years, most people in developed countries won’t have sex to procreate. That’s what Stanford law professor and bioethicist Hank Greely predicts: a future where skin cells can be used to make an embryo and parents would prefer a baby made in a laboratory rather than the bedroom. In [...]